Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Operating Cash Flow 2011-2024 | EGRX

Annual Operating Cash Flow Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
50.7 M 28.2 M 49.5 M 56 M 52.4 M 58.9 M 53.2 M -9.72 M -13.8 M -5.88 M -15.5 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
58.9 M -15.5 M 27.6 M

Quarterly Operating Cash Flow Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- -33.5 M - 13.1 M 26.4 M -16.6 M - 20.1 M 19.1 M 10.5 M - 29.7 M 24.1 M 3.16 M - 59.2 M 48.6 M 26.2 M - 14.3 M 10.6 M 4.92 M - 33 M 25.1 M -12.4 M - 13.7 M 484 K 3.11 M - 7.08 M 13.7 M 25.8 M -7.88 M -13.9 M -6.74 M -2.07 M 23 K -5.56 M -2.83 M - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
59.2 M -33.5 M 10.3 M